Live
- Vizag mafia rules sand ramps in Srikakulam district
- Unselfishness is a Lie
- ICTPL welcomes maiden vessel MV KSL Fuyang
- BJP leaders mock Rahul's speech
- Analysing Happiness
- Two-day ToT organised for trainers
- Savarkar preferred Manusmriti to Constitution: Rahul
- Daily Horoscope for 15 December 2024: Embrace Today’s Insights of Your Zodiac Sign and Unlock Your Potential.
- Beyond The Flames
- CM warns officials of stringent action
Just In
21k positive after taking first dose of Covishield, Covaxin
More than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said on Wednesday
New Delhi: More than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said on Wednesday.
Addressing a press conference, ICMR Director General Balram Bhargava said 0.04 per cent of 17,37,178 individuals, who received the second dose of Covaxin, were positive for COVID-19, while 0.03 per cent of 1,57,32,754 people, who took the second dose of Covishield, contracted the infection. Bhargava who presented the data said vaccines reduce the risk of infection and prevent death and severe infection.
"After vaccination if one gets infection then it is known as breakthrough infection," he said. So far, 1.1 crore doses of Covaxin have been administered. Out of which 93 lakh received the first dose and out of that 4,208 (0.04 per cent) people got the infection which is four per 10,000 individuals. About 17,37,178 people received the second dose of which only 695 (0.04 per cent) tested positive for COVID-19, Bhargava said. Of Covishield, 11.6 crore doses have been given.
Ten crore received the first dose and 17,145 i.e. 2 per 10,000 people contracted the infection. About 1,57,32,754 individuals took the second dose of covishield and of that 5,014 (0.03 per cent) got infected.
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com